tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:6BG Stock Latest News

Insider-Linked Investor Takes Major Allocation in Lytix Biopharma Share Issue
Company AnnouncementsInsider-Linked Investor Takes Major Allocation in Lytix Biopharma Share Issue
2d ago
6BG
Lytix Biopharma Lines Up NOK 30m Subsequent Share Offering After Private Placement
PremiumCompany Announcements
Lytix Biopharma Lines Up NOK 30m Subsequent Share Offering After Private Placement
2d ago
6BG
Lytix Biopharma Raises NOK 61 Million in Oversubscribed Private Placement and Plans Repair Offering
PremiumCompany Announcements
Lytix Biopharma Raises NOK 61 Million in Oversubscribed Private Placement and Plans Repair Offering
2d ago
6BG
Lytix Biopharma’s Promising Update: Phase 2 Study on Advanced Melanoma Treatment Completed
PremiumCompany Announcements
Lytix Biopharma’s Promising Update: Phase 2 Study on Advanced Melanoma Treatment Completed
28d ago
6BG
Lytix Biopharma to Release Q3 2025 Financial Results
PremiumCompany Announcements
Lytix Biopharma to Release Q3 2025 Financial Results
2M ago
6BG
Lytix Biopharma Reports Promising Interim Results in Melanoma Study
PremiumCompany AnnouncementsLytix Biopharma Reports Promising Interim Results in Melanoma Study
2M ago
6BG
Lytix Biopharma’s Ruxotemitide Shows Promising Results in Cancer Immunotherapy
Premium
Company Announcements
Lytix Biopharma’s Ruxotemitide Shows Promising Results in Cancer Immunotherapy
2M ago
6BG
Lytix Biopharma’s Partner to Present Promising Phase II Trial Data at SITC
Premium
Company Announcements
Lytix Biopharma’s Partner to Present Promising Phase II Trial Data at SITC
3M ago
6BG
Lytix Biopharma Strengthens Management Incentives with Share Options
PremiumCompany Announcements
Lytix Biopharma Strengthens Management Incentives with Share Options
4M ago
6BG
Lytix Biopharma Advances Ruxotemitide in Cancer Treatment with Promising H1 2025 Results
PremiumCompany Announcements
Lytix Biopharma Advances Ruxotemitide in Cancer Treatment with Promising H1 2025 Results
5M ago
6BG
Lytix Biopharma to Announce Q2 2025 Financial Results
PremiumCompany Announcements
Lytix Biopharma to Announce Q2 2025 Financial Results
5M ago
6BG
Lytix Biopharma Grants Share Options to Board Members
PremiumCompany Announcements
Lytix Biopharma Grants Share Options to Board Members
8M ago
6BG
Lytix Biopharma Reports Strong Q1 2025 Results and Strategic Advancements
PremiumCompany AnnouncementsLytix Biopharma Reports Strong Q1 2025 Results and Strategic Advancements
8M ago
6BG
Lytix Biopharma Strengthens Board to Boost Immuno-Oncology Focus
Premium
Company Announcements
Lytix Biopharma Strengthens Board to Boost Immuno-Oncology Focus
9M ago
6BG
Lytix Biopharma Announces Board Chair Resignation Amid Strategic Developments
Premium
Company Announcements
Lytix Biopharma Announces Board Chair Resignation Amid Strategic Developments
9M ago
6BG
Lytix Biopharma Announces Annual General Meeting Amidst Cancer Treatment Innovations
PremiumCompany Announcements
Lytix Biopharma Announces Annual General Meeting Amidst Cancer Treatment Innovations
9M ago
6BG
Lytix Biopharma’s LTX-315 Shows Promising Results as It Eyes Phase III Trials
PremiumCompany Announcements
Lytix Biopharma’s LTX-315 Shows Promising Results as It Eyes Phase III Trials
11M ago
6BG
Lytix Biopharma Secures U.S. Patent for Cancer Therapy
PremiumCompany Announcements
Lytix Biopharma Secures U.S. Patent for Cancer Therapy
11M ago
6BG
Lytix Biopharma to Announce Q4 2024 Financial Results
PremiumCompany Announcements
Lytix Biopharma to Announce Q4 2024 Financial Results
11M ago
6BG
Lytix Biopharma’s LTX-315 Shows Promising Results in BCC Treatment
PremiumCompany AnnouncementsLytix Biopharma’s LTX-315 Shows Promising Results in BCC Treatment
12M ago
6BG
Lytix Biopharma Completes Capital Raise of NOK 111.3 Million
Premium
Company Announcements
Lytix Biopharma Completes Capital Raise of NOK 111.3 Million
12M ago
6BG
Lytix Biopharma Halts Additional Share Offering After Successful Fundraising
Premium
Company Announcements
Lytix Biopharma Halts Additional Share Offering After Successful Fundraising
1y ago
6BG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >